| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VTYX | Common Stock | Sale | -$68.2K | -2.09K | -7.53% | $32.69 | 25.6K | Aug 8, 2023 | By Spouse | F1, F2 |
| transaction | VTYX | Common Stock | Sale | -$46.6K | -1.41K | -5.5% | $33.12 | 24.2K | Aug 8, 2023 | By Spouse | F1, F3 |
| holding | VTYX | Common Stock | 48.4K | Aug 8, 2023 | Direct |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on December 19, 2022. |
| F2 | Represents the weighted average share price of an aggregate total of 2,086 shares sold in the price range of $32.0441 to $33.0225. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Represents the weighted average share price of an aggregate total of 1,408 shares sold in the price range of $33.055 to $33.37. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
President and Chief Medical Officer